Login
$HIT
$0.33 -$0.07 (16.61%) Live

Who owns Health?

Institutions own, across all of Health's classes
—
of the economics
—
of the votes

Refinery's class records do not yet say which CUSIP each class trades under, so 13F holdings cannot be split by class or combined across them.

By class
Class Shares outstanding Held by institutions Votes a share Economics a share
HIT 67.1M — 1 vote 1
Class B 12.6M — 10 votes 1

SEC filing ea0283147-10k_health.htm: Our Class B Common Stock have 10 votes per share, and our Class A Common Stock have one vote per share. The holders of our outstanding Class B Common Stock, which consist of our Chief Executive Officer and our Chief Financial Officer, beneficially own 75.42% of our outstanding capital stock and hold 91.02% of the voting power of our outstanding capital stock. Further, we may issue additional sh...

How is ownership changing?

Institutions, last 8 quarters

A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.

Biggest buyers in Q2 2026
  • Whetstone Capital Advisors, LLC NEW +1.5M
  • Mink Brook Asset Management LLC +326.9K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Heights Capital Management, Inc SOLD OUT −373.3K
  • Two Sigma Investments, LP SOLD OUT −52.3K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$44.3K
3 notices from 2 people
Arranged in advance
39%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$22.2K$44.3KDecJanFebMarAprMayJunJulAugSep 2026: $17.2K under a 10b5-1 planSep 2026: $27.1K without a planSepOctNov
Largest proposed sellers
  • Hayes Timothy Director $27.1K
  • Hasan Zain Syed Chief growth officer 10b5-1 $17.2K
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2024–FY2025
+7.6%
+7.60% a year
Each share's claim on the business
−7.1%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $2.04M
over 2 fiscal years
Diluted shares, split-adjusted
52.1M55.2M58.3M2024: 53.7M shares'242025: 57.7M shares'25
Buybacks Stock-based comp
$0$785.2K$1.6M2024 buybacks: $02024 stock comp: $468.5K'242025 buybacks: $02025 stock comp: $1.6M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%
Quarterly turnover
53.2%
of institutional shares changed hands
Top 10 managers, median time held
3 quarters

Super Investors

Investment managers reporting Health on Form 13F
WC
Whetstone Capital Advisors, LLC
Shares
1.5M
% of company
—
Change vs last qtr
NEW
Held since
Q2 '26
MB
Mink Brook Asset Management LLC
Shares
1.1M
% of company
—
Change vs last qtr
+326.9K (+40.5%)
Held since
Q1 '26

21 more super investors behind a free account

See every manager holding Health In Tech, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Health on Form N-PORT
VT
Position value
$410K
% of company
—
% of the fund
0.00%
As of
June 30, 2026
VE
Position value
$161K
% of company
—
% of the fund
0.00%
As of
June 30, 2026

7 more funds behind a free account

See every fund holding Health In Tech, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
JT
Johnson Tim Donald
Insider
Shares
26.2M
% of company
—
Change vs last qtr
—
Held since
—
QL
Qian LinLin
Insider
Shares
12.0M
% of company
—
Change vs last qtr
—
Held since
—

15 more holders behind a free account

See every insider and 5%+ holder of Health In Tech, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support